Dr. Frank Borriello will be participating in Roth’s Capital Partners’ Virtual Healthcare Private Company Forum on June 28 as part of Cancer Panel 2: entitled Natural Killer Cell Approaches to Eradicate Tumors where he will be highlighting the differentiation of the Alloplex approach in the oncology cellular therapy space.
The panel is to be hosted by Roth’s Capital Partners’ analyst Tony Butler, PhD.